Galcanezumab improves interictal burden in patients with migraine with multiple treatment failuresMarch 30, 2023Headache & Migraine
CGRP monoclonal antibodies and gepants: Safe and well-tolerated options for migraine preventionMarch 30, 2023Headache & Migraine
Intranasal zavegepant shows potential as an effective treatment option for acute migraineMarch 30, 2023Headache & Migraine
Commentary: Pregnancy, photophobia, and stroke in relation to migraine, March 2023March 1, 2023Headache & Migraine
‘Quick, affordable’ test helps predict CGRP response for migraineFebruary 22, 2023Headache & Migraine
Premenopausal women with migraine history have poor sleep qualityFebruary 14, 2023Headache & Migraine
Association between migraine and stroke in middle-aged and elderly populationsFebruary 14, 2023Headache & Migraine
Acupuncture may be an effective alternative to fremanezumab in episodic migraineFebruary 14, 2023Headache & Migraine
Difficult-to-treat chronic migraine: OnabotulinumtoxinA to anti-CGRP mAbs switch shows benefitFebruary 14, 2023Headache & Migraine
Eptinezumab improves patient-reported outcomes in migraine and medication-overuse headacheFebruary 14, 2023Headache & Migraine
Rimegepant effective in patients with migraine and an inadequate response to 1 or ≥2 triptansFebruary 14, 2023Headache & Migraine
